Stay updated on CHF 6532 in Severe Eosinophilic Asthma Clinical Trial
Sign up to get notified when there's something new on the CHF 6532 in Severe Eosinophilic Asthma Clinical Trial page.

Latest updates to the CHF 6532 in Severe Eosinophilic Asthma Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check22 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check29 days agoNo Change Detected
- Check36 days agoChange DetectedThe web page has undergone significant changes, including the removal of detailed descriptions of a phase III study evaluating CHF 6532 for severe eosinophilic asthma, while retaining some basic study information such as the study's location and design aspects like being placebo-controlled and double-blind.SummaryDifference39%
- Check43 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check87 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check101 days agoChange DetectedThe page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
- Check108 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.1%
Stay in the know with updates to CHF 6532 in Severe Eosinophilic Asthma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CHF 6532 in Severe Eosinophilic Asthma Clinical Trial page.